News & Views
Radiotherapy System to Tackle Higher Patient Numbers in Japan
May 07 2019 Read 369 Times
Ofuna Chuo Hospital, Kamakura City, Kanagawa Prefecture, Japan has become the first clinic in the country to begin treating cancer patients using Halcyon™, Varian’s intensity modulated radiotherapy (IMRT) system, which offers improved patient comfort and fewer treatment steps than older technology.
To assist in the reduction of time and construction costs from installation to first patient treatment, Halcyon offers expedited commissioning, requires less shielding than traditional systems, can fit in the majority of existing small vaults and can be installed in two weeks or less, according to the company.
"The Ofuna Chuo Hospital is a regional core hospital in the south-eastern part of Kanagawa Prefecture and provides radiation treatment to more than 800 patients annually," said Dr. Atsuya Takeda, director of Radiation Oncology Center, Ofuna Central Hospital. "By introducing Halcyon, IMRT and intensity-modulated rotational radiation therapy (VMAT), we expect to treat more patients by being able to efficiently carry out high-precision radiation therapy."
"We are proud to collaborate with Ofuna Chuo Hospital to be the first to have Halcyon in Japan," said Mitchell Silong, senior managing director, Varian Medical Systems KK. "With Halcyon, together, we expect to deliver high quality care in a patient-centric environment to more patients, helping to create a world without fear of cancer."
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Mass Spectrometry & Spectroscopy - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - Non-equivalent, Multivalen...
View all digital editions
Dec 13 2019 Kathmandu, Nepal
Jan 25 2020 San Diego, CA, USA
Jan 27 2020 Dubai, UAE
Jan 29 2020 Tokyo, Japan
Jan 29 2020 Ghent, Belgium